Published in N Engl J Med on October 31, 1996
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26
Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ (2005) 2.23
Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nat Chem (2009) 2.19
New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ (2001) 2.12
Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ (2012) 2.02
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation (2008) 1.95
Was it a heart attack? BMJ (2002) 1.95
Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol (2011) 1.79
Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care (2005) 1.57
Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation (2011) 1.47
Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions. Transfusion (2015) 1.46
Raised cardiac troponin T levels in patients without acute coronary syndrome. Postgrad Med J (2007) 1.39
Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc (2009) 1.38
The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care (2005) 1.36
Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci U S A (1999) 1.23
Biomarkers in acute myocardial infarction. BMC Med (2010) 1.22
Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart (2002) 1.22
Epidemiology of myocardial infarction. Med Clin North Am (2007) 1.18
Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics (2009) 1.18
A highly sensitive and selective diagnostic assay based on virus nanoparticles. Nat Nanotechnol (2009) 1.15
Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Kidney Int (2014) 1.11
Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart. FASEB J (2014) 1.09
Early diagnosis of myocardial infarction: why measure cardiac enzymes? J Clin Pathol (1998) 1.07
Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circ Res (2011) 1.04
High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction. Crit Care (2011) 1.03
Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med (2012) 1.02
Point-of-care technologies for molecular diagnostics using a drop of blood. Trends Biotechnol (2014) 0.99
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury. Biomark Insights (2012) 0.97
Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels (2010) 0.97
The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag (2010) 0.97
Magnetic nanoparticle mediated enhancement of localized surface plasmon resonance for ultrasensitive bioanalytical assay in human blood plasma. Anal Chem (2013) 0.97
No pain, but no gain? The disappearance of angina hospitalizations, 1992-1999. Med Care (2009) 0.94
Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury. Mol Cell Proteomics (2015) 0.93
Cardiac troponins. J Clin Pathol (2004) 0.92
Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol (2007) 0.92
The British Cardiac Society Working Group definition of myocardial infarction: implications for practice. Heart (2005) 0.92
Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc (2013) 0.92
Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study. Am Heart J (2009) 0.91
Thin filament remodeling in failing myocardium. Heart Fail Rev (2005) 0.90
Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2005) 0.90
Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis (2013) 0.88
Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart (2005) 0.88
High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc (2014) 0.88
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. J Am Heart Assoc (2016) 0.88
Role of biomarkers in risk stratification of acute coronary syndrome. Indian J Med Res (2010) 0.87
Management of acute coronary syndromes: an update. Heart (2004) 0.86
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study. BMC Health Serv Res (2013) 0.86
Predictive value of initial triage vital signs for critically ill older adults. West J Emerg Med (2013) 0.85
Ischaemic symptoms, quality of care and mortality during myocardial infarction. Heart (2007) 0.85
Can C reactive protein or troponins T and I predict outcome in patients with intractable unstable angina? Heart (1998) 0.84
Cardiac troponins in acute coronary syndromes. N Engl J Med (1996) 0.84
Histamine blood concentration in ischemic heart disease patients. J Biomed Biotechnol (2011) 0.84
Cardiac troponins in chest pain can help in risk stratification. BMJ (1999) 0.83
Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram. Am J Cardiol (2008) 0.83
Troponin in patients with chest pain. BMJ (2004) 0.83
Comparison of traditional cardiovascular risk models and coronary atherosclerotic plaque as detected by computed tomography for prediction of acute coronary syndrome in patients with acute chest pain. Acad Emerg Med (2012) 0.82
A new scoring system to stratify risk in unstable angina. BMC Cardiovasc Disord (2003) 0.82
Implications of troponin testing in clinical medicine. Curr Control Trials Cardiovasc Med (2001) 0.81
Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance. Oman Med J (2011) 0.81
Myocardial infarction: redefined or reinvented? Heart (2002) 0.81
High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy. Springerplus (2014) 0.81
The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomedicine (2013) 0.81
A predictive instrument using contrast echocardiography in patients presenting to the emergency department with chest pain and without ST-segment elevation. J Am Soc Echocardiogr (2010) 0.81
Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry. Clin Res Cardiol (2014) 0.81
Cardiac troponins in intensive care. Crit Care (2005) 0.80
Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study. BMJ Open (2014) 0.80
Critical review of unstable angina and non-ST elevation myocardial infarction. Postgrad Med J (2002) 0.80
The impact of antibody selection on the detection of cardiac troponin I. Clin Chim Acta (2012) 0.80
When prognosis precedes diagnosis: putting the cart before the horse. CMAJ (2005) 0.79
Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome. PLoS One (2014) 0.79
Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage. J Clin Med Res (2012) 0.79
Diagnostic implications of an elevated troponin in the emergency department. Dis Markers (2015) 0.79
Clinical risk scoring beyond initial troponin values: results from a large, prospective, unselected acute chest pain population. Can J Cardiol (2007) 0.79
Acute myocardial infarct size is related to periodontitis extent and severity. J Dent Res (2014) 0.79
Diagnosis and Diagnostic Modalities in Pediatric Patients with Elevated Troponin. Pediatr Cardiol (2016) 0.78
Redefining myocardial infarction for the 21st century. Trans Am Clin Climatol Assoc (2004) 0.78
Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy. Curr Heart Fail Rep (2015) 0.78
Cardiac Troponins in Dogs and Cats. J Vet Intern Med (2015) 0.78
The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study. PLoS One (2014) 0.77
A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) IND 130. Invest New Drugs (2005) 0.77
Effects of heated hydrotherapy on muscle HSP70 and glucose metabolism in old and young vervet monkeys. Cell Stress Chaperones (2016) 0.77
Red blood cell distribution width is associated with myocardial injury in non-ST-elevation acute coronary syndrome. Clinics (Sao Paulo) (2015) 0.76
Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronary syndromes. Int J Cardiovasc Imaging (2004) 0.76
Implications of the new definition of myocardial infarction. Postgrad Med J (2005) 0.76
Imperfect gold standards for biomarker evaluation. Clin Trials (2013) 0.76
Cardioprotection from ischemia-reperfusion injury by near-infrared light in rats. Photomed Laser Surg (2014) 0.76
Unusual towering elevation of troponin I after ST-elevation myocardial infarction and intensive monitoring with echocardiography post-percutaneous coronary intervention: a case report. J Med Case Rep (2010) 0.75
The incremental value of troponin biomarkers in risk stratification of acute coronary syndromes: is the relationship multiplicative? Open Cardiovasc Med J (2009) 0.75
Serum markers in myocardial infarction. J Clin Pathol (1999) 0.75
Association between angiotensin-converting enzyme inhibitors and troponin in acute coronary syndrome. Arq Bras Cardiol (2014) 0.75
Recent advances in the management of unstable angina and non-Q-wave myocardial infarction. Br J Clin Pharmacol (1998) 0.75
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
A simple and rapid method for the preparation of plant genomic DNA for PCR analysis. Nucleic Acids Res (1991) 11.96
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Engineering herbicide resistance in plants by expression of a detoxifying enzyme. EMBO J (1987) 6.77
The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation (1982) 5.56
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci U S A (1999) 4.62
TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation (1996) 4.41
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet (2011) 4.35
Myocardial infarct size and ventricular function in rats. Circ Res (1979) 4.33
A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med (1999) 4.24
Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest (1965) 4.23
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
A trial of two strategies to modify the test-ordering behavior of medical residents. N Engl J Med (1980) 3.98
Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation (1968) 3.82
Novel form of growth cone motility involving site-directed actin filament assembly. Nature (1992) 3.73
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA (1997) 3.68
Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol (1971) 3.68
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
The unhealthy lifestyle of people with schizophrenia. Psychol Med (1999) 3.54
Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ (1999) 3.52
Aortic stenosis. Circulation (1968) 3.49
Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science (1999) 3.40
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med (1971) 3.24
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (2009) 3.13
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet (2001) 3.07
Mechanism of action of calcium-channel-blocking agents. N Engl J Med (1982) 2.99
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med (1988) 2.98
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation (2000) 2.93
Improving response to critical laboratory results with automation: results of a randomized controlled trial. J Am Med Inform Assoc (1999) 2.88
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet (2001) 2.78
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer (1989) 2.68
Appropriateness of antiepileptic drug level monitoring. JAMA (1995) 2.67
Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem (1997) 2.66
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
Intergeneric conjugation between Escherichia coli and Streptomyces species. J Bacteriol (1989) 2.62
Regeneration of a functional RNA virus genome by recombination between deletion mutants and requirement for cowpea chlorotic mottle virus 3a and coat genes for systemic infection. Proc Natl Acad Sci U S A (1990) 2.61
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. J Clin Invest (1967) 2.51
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
The epidemiology of infertility in Aberdeen. BMJ (1990) 2.44
Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol (1991) 2.40
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
How fast is fast enough for clinical laboratory turnaround time? Measurement of the interval between result entry and inquiries for reports. Am J Clin Pathol (1997) 2.36
Unstable angina: an etiologic approach to management. Circulation (1998) 2.31
The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation (1965) 2.30
Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol (1968) 2.29
Coronary-artery surgery at the crossroads. N Engl J Med (1977) 2.28
Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest (1973) 2.28
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J (2001) 2.28
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Coronary-artery spasm. N Engl J Med (1978) 2.20
Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med (1980) 2.20
Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol (1986) 2.20
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med (1980) 2.19
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol (1972) 2.19
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation (1999) 2.16
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation (1995) 2.16
Bacterial SOS checkpoint protein SulA inhibits polymerization of purified FtsZ cell division protein. J Bacteriol (1998) 2.15
What proportion of common diagnostic tests appear redundant? Am J Med (1998) 2.15
Assessment of cardiac contractility. The relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation (1971) 2.15
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol (1965) 2.11
OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant (2015) 2.11